Page last updated: 2024-10-16

carnitine and Carcinoma, Transitional Cell

carnitine has been researched along with Carcinoma, Transitional Cell in 1 studies

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"Our previous high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry study identified bladder cancer (BCA)-specific urine metabolites, including carnitine, acylcarnitines, and melatonin."3.83Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls. ( Choi, YD; Choi, YH; Jeong, P; Kang, HW; Kim, IY; Kim, J; Kim, WJ; Kim, WT; Kim, YH; Lee, IS; Moon, SK; Park, S; Yan, C; Yun, SJ, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, WT1
Yun, SJ1
Yan, C1
Jeong, P1
Kim, YH1
Lee, IS1
Kang, HW1
Park, S1
Moon, SK1
Choi, YH1
Choi, YD1
Kim, IY1
Kim, J1
Kim, WJ1

Other Studies

1 other study available for carnitine and Carcinoma, Transitional Cell

ArticleYear
Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
    Yonsei medical journal, 2016, Volume: 57, Issue:4

    Topics: Aged; Biomarkers; Carcinoma, Transitional Cell; Carnitine; Case-Control Studies; Female; Humans; Mal

2016